tirzepatide side affects vs Semaglutide: Which Weight Loss Medication Works Better? Tirzepatide for Medical Weight Loss
Description
By targeting both GIP and GLP-1 pathways, it offers a distinct approach to influencing appetite, blood sugar, and fat storage compared to semaglutides single-pathway action
Both are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
In line with this, the gastric emptying delay induced by GLP-1RAs is dependent on the presence of GLP-1Rs on these vagal afferents (Imeryuz et al., 1997)
Instant activation is available at mounjaro.lilly.com/savings-resources or by texting "MJ" to 85099
